Immunological features of coronavirus disease 2019 in patients with cancer.
Fiche publication
Date publication
septembre 2020
Journal
European journal of cancer (Oxford, England : 1990)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GHIRINGHELLI François, Dr LIMAGNE Emeric, Dr FUMET Jean-David, Dr THIBAUDIN Marion
Tous les auteurs :
Thibaudin M, Fumet JD, Bon M, Hampe L, Limagne E, Ghiringhelli F
Lien Pubmed
Résumé
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has caused a major pandemic. Patients with cancer are at higher risk of severe COVID-19. We aimed to describe and compare the immunological features of cancer patients hospitalised for COVID-19 or other concomitant, cancer-related illness.
Mots clés
COVID-19, Cancer, Immunomonitoring
Référence
Eur. J. Cancer. 2020 Sep 7;139:70-80